Skip to main content
SpringerLink
Log in

Primary chemotherapy for breast cancer — MD Anderson experience

  • Conference paper
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy

Abstract

Primary chemotherapy (PCT) was introduced as an experimental approach for the treatment of locally advanced (LABC) and inflammatory breast cancer (IBC) at this institution in 1973. It was our hypothesis that PCT would simultaneously downstage the patients and control micrometastases [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hortobagyi GN, Buzdar AU (1990) Locally advanced breast cancer: The MD Anderson Experience. In: Ragaz J, Ariel IM (eds) High-risk breast cancer II. Springer-Verlag, Heidelberg, p 382

    Google Scholar 

  2. Hortobagyi GN, Ames FC, Buzdar AU, et al (1988) Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62: 2507

    Article  PubMed  CAS  Google Scholar 

  3. Hortobagyi GN, Buzdar AU, Ames FC, McNeese MD (1988) neo-adjuvant chemotherapy in the management of advanced primary carcinoma of the breast. In: Jacquillat C, Weil M, Khayat D (eds) neo-adjuvant chemotherapy. Colloque INSERM John Libbey Eurotext Ltd, vol. 169, p 137

    Google Scholar 

  4. Hortobagyi G, Holmes F, Frye D (1990) Comparison of two adjuvant chemotherapy programs for locally advanced breast cancer: a prospective randomized trial. Proceedings of the 26th Annual Meeting of the American Society of Clinical Oncology, 9: 21 (abstract 77)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MD Anderson Cancer Center, Departments of Medical Oncology, Breast Medical Oncology, The University of Texas, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

    G. N. Hortobagyi, A. U. Buzdar, F. A. Holmes & R. L. Theriault

  2. MD Anderson Cancer Center, Departments of Medical Oncology, General Surgery, The University of Texas, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

    S. E. Singletary & M. I. Ross

  3. MD Anderson Cancer Center, Departments of Medical Oncology, Clinical Radiotherapy, The University of Texas, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

    M. D. McNeese & E. Strom

  4. MD Anderson Cancer Center, Departments of Medical Oncology, Anatomic Pathology, The University of Texas, 1515 Holcombe Boulevard, Houston, Texas, 77030, USA

    N. Sneige

Authors
  1. G. N. Hortobagyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. E. Singletary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. U. Buzdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. D. McNeese
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. I. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. A. Holmes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Strom
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. L. Theriault
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N. Sneige
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital Saint-Louis, 1, avenue Vellefaux, 75475, Paris Cedex 10, France

    P. Banzet

  2. The Mount Sinai Medical Center, 1 G. Levy Place, 10029-6574, New York, NY, USA

    J. F. Holland

  3. Service d’Oncologie Médicale, Hôpital Pitié-Salpétrière, Pavillon Jacquart, 47, boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    D. Khayat

  4. Hôpital Pitié-Salpétrière, Pavillon Jacquart, 47, boulevard de l’Hôpital, 75651, Paris Cedex 13, France

    M. Weil

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag France

About this paper

Cite this paper

Hortobagyi, G.N. et al. (1991). Primary chemotherapy for breast cancer — MD Anderson experience. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy. Springer, Paris. https://doi.org/10.1007/978-2-8178-0782-9_35

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0782-9_35

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0784-3

  • Online ISBN: 978-2-8178-0782-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation